至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

The SUMO-specific isopeptidase SENP2 is targeted to intracellular membranes via a predicted N-terminal amphipathic α-helix.

Mol. Biol. Cell. 2018-08; 
OdehHana M,CoyaudEtienne,RaughtBrian,MatunisMicha
Products/Services Used Details Operation
Catalog Antibody … Aldrich, St. Louis, MO); anti-calnexin (Enzo Life Sciences, Inc., Farmingdale, NY); anti-MBP (GenScript, Piscataway, NJ); anti-FLAG M2 (Sigma-Aldrich, St. Louis, MO); anti-His (Sigma- Aldrich, St. Louis, MO); anti-GM130 (BD Biosciences, San Jose, CA); anti-GRP78 (Santa Cruz … Get A Quote

摘要

Sumoylation regulates a wide range of essential cellular functions, many of which are associated with activities in the nucleus. Although there is also emerging evidence for the involvement of the small ubiquitin-related modifier (SUMO) at intracellular membranes, the mechanisms by which sumoylation is regulated at membranes is largely unexplored. In this study, we report that the SUMO-specific isopeptidase, SENP2, uniquely associates with intracellular membranes. Using in vivo analyses and in vitro binding assays, we show that SENP2 is targeted to intracellular membranes via a predicted N-terminal amphipathic α-helix that promotes direct membrane binding. Furthermore, we demonstrate that SENP2 b... More

关键词